Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4;13(3):223.
doi: 10.3390/pathogens13030223.

Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection

Affiliations

Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection

Benjamin Lee et al. Pathogens. .

Abstract

The infant non-secretor histoblood group antigen phenotype is associated with reduced risk of symptomatic rotavirus diarrhea, one of the leading global causes of severe pediatric diarrheal disease and mortality. However, little is known regarding the role of secretor status in asymptomatic rotavirus infections. Therefore, we performed a nested case-control study within a birth cohort study previously conducted in Dhaka, Bangladesh, to determine the association between infant secretor phenotype and the odds of asymptomatic rotavirus infection, in addition to the risk of rotavirus diarrhea, in unvaccinated infants. In the parent cohort, infants were enrolled in the first week of life and followed through the first two years of life with multiple clinic visits and active surveillance for diarrheal illness. Secretor phenotyping was performed on saliva. Eleven surveillance stools collected over the first year of life were tested for rotavirus by real-time RT-PCR, followed by conventional PCR and amplicon sequencing to identify the infecting P-type of positive specimens. Similar to findings for symptomatic diarrhea, infant non-secretors experienced significantly fewer primary episodes of asymptomatic rotavirus infection through the first year of life in a likely rotavirus P-genotype-dependent manner. These data suggest that non-secretors experienced reduced risk from rotavirus due to decreased susceptibility to infection rather than reduced infection severity.

Keywords: FUT2; diarrhea; gastroenteritis; histoblood group antigen; rotavirus; secretor.

PubMed Disclaimer

Conflict of interest statement

E. Ross Colgate’s current affiliation is The Emmes Company, all authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Cumulative incidence of rotavirus infection in unvaccinated children through year 1 of life according to secretor phenotype. Cumulative incidence of (A) asymptomatic rotavirus infection in unvaccinated children who remained RV diarrhea-free through year 1 of life, and (B) any rotavirus infection (symptomatic RV diarrhea or asymptomatic infection) by each indicated time point. The numbers above each bar indicate the percentage of evaluable children with infection by that time point, along with the absolute number of children with infection by that time point in parentheses. * p < 0.05.

Similar articles

References

    1. Lee B. Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines. Hum. Vaccines Immunother. 2020;17:1787–1802. doi: 10.1080/21645515.2020.1844525. - DOI - PMC - PubMed
    1. Troeger C., Khalil I.A., Rao P.C., Cao S., Blacker B.F., Ahmed T., Armah G., Bines J.E., Brewer T.G., Colombara D.V., et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. JAMA Pediatr. 2018;172:958–965. doi: 10.1001/jamapediatrics.2018.1960. - DOI - PMC - PubMed
    1. Cohen A.L., A Platts-Mills J., Nakamura T., Operario D.J., Antoni S., Mwenda J.M., Weldegebriel G., Rey-Benito G., de Oliveira L.H., Ortiz C., et al. Aetiology and incidence of diarrhoea requiring hospitalisation in children under 5 years of age in 28 low-income and middle-income countries: Findings from the Global Pediatric Diarrhea Surveillance network. BMJ Glob. Health. 2022;7:e009548. doi: 10.1136/bmjgh-2022-009548. - DOI - PMC - PubMed
    1. Sadiq A., Khan J. Rotavirus in developing countries: Molecular diversity, epidemiological insights, and strategies for effective vaccination. Front. Microbiol. 2023;14:1297269. doi: 10.3389/fmicb.2023.1297269. - DOI - PMC - PubMed
    1. Burnett E., Parashar U.D., Tate J.E. Real-world effectiveness of rotavirus vaccines, 2006–2019: A literature review and meta-analysis. Lancet Glob. Health. 2020;8:e1195–e1202. doi: 10.1016/S2214-109X(20)30262-X. - DOI - PMC - PubMed

MeSH terms

Substances